WallStSmart
EVO

Evotec SE ADR

NASDAQ: EVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$3.11
+5.78% today

Updated 2026-04-30

Market cap
$1.04B
P/E ratio
P/S ratio
1.33x
EPS (TTM)
$-0.34
Dividend yield
52W range
$2 – $5
Volume
0.1M

Evotec SE ADR (EVO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-9.22M$-31.67M$-41.28M$-21.85M$899000.00$10.15M$11.96M$6.66M$-3.80M$15.65M$67.36M$10.83M$156.24M$42.22M$44.72M$122.24M$205.81M$33.95M$18.22M$-9.06M
Capital expenditures$2.56M$4.35M$3.51M$2.21M$2.43M$8.14M$10.18M$5.19M$5.28M$11.50M$10.15M$17.59M$27.87M$31.91M$99.07M$118.94M$181.35M$216.00M$132.24M$69.68M
Depreciation
Stock-based comp$1.13M$1.02M$1.68M$960000.00$1.51M$1.25M$1.50M$3.97M$3.98M$2.92M$4.25M$3.65M$5.29M$7.80M$9.92M$9.63M$5.04M$3.78M
Free cash flow$-11.78M$-36.02M$-44.79M$-24.07M$-1.53M$2.01M$1.78M$1.47M$-9.08M$4.16M$57.21M$-6.76M$128.37M$10.31M$-54.35M$3.29M$24.46M$-182.05M$-114.02M$-78.74M
Investing cash flow
Financing cash flow
Dividends paid$7.44M$6.04M$4.06M$383000.00$278000.00$1.81M$551000.00$2.02M$1.72M$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash